http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111686226-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111686226-B |
| titleOfInvention | Traditional Chinese medicine composition for treating colon cancer and preparation method and application thereof |
| abstract | The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating colon cancer, which comprises the following active ingredients in parts by weight: 2-4 parts of radix astragali, 0.5-1 part of herba epimedii, 1-1.5 parts of red paeony root, 0.5-1 part of rhizoma zedoariae, 1.5-3 parts of rhizoma smilacis glabrae and 0.5-1.5 parts of fried bighead atractylodes rhizome. The invention also provides a preparation method and application of the traditional Chinese medicine composition for treating colon cancer. Experiments of colon cancer tumor-bearing mice show that when the traditional Chinese medicine composition for treating colon cancer is combined with chemotherapeutic drugs for application, although the tumor inhibition effect of the chemotherapeutic drugs is not obviously enhanced, the traditional Chinese medicine composition can obviously prolong the survival time of the mice, relieve the weight loss caused by the chemotherapeutic drugs, improve the T lymphocyte level of the mice, and especially obviously improve CD4 + T lymphocytes, CD8 + The T lymphocyte level shows that the traditional Chinese medicine composition for treating colon cancer can improve the body immunity of a colon cancer patient, so that the life quality of the patient is improved, and the survival time is prolonged. |
| priorityDate | 2020-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.